Lung cancer symptom scale outcomes in relation to standard efficacy measures: An analysis of the phase III study of pemetrexed versus docetaxel in advanced non-small cell lung cancer

Filippo De Marinis, Jose Rodrigues Pereira, Frank Fossella, Michael C. Perry, Martin Reck, Marc Salzberg, Jacek Jassem, Patrick Peterson, Astra M. Liepa, Patti Moore, Richard J. Gralla

Research output: Contribution to journal › Article › peer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Lung cancer symptom scale outcomes in relation to standard efficacy measures: An analysis of the phase III study of pemetrexed versus docetaxel in advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences